A physiologically relevant, estradiol-17β [E2]-responsive in vitro tissue-engineered model of the vaginal epithelium for vaginal tissue research.
preclinical models
sheep
tissue-engineered vagina
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
22
01
2022
accepted:
11
02
2022
pubmed:
22
3
2022
medline:
30
4
2022
entrez:
21
3
2022
Statut:
ppublish
Résumé
There are many situations where preclinical models of the human vagina would be valuable for in vitro studies into the pathophysiology of vaginally transmitted diseases, microbicide efficacy, irritability testing, and particularly, for assessing materials to be inserted in the vagina for support of the pelvic floor. The aim of this study is to develop a physiologically relevant, low cost, and ethically suitable model of the vagina using sheep vaginal tissue (SVT) to reduce the need for animal testing in gynecological research. Tissue-engineered (TE) vaginal models were developed by culturing primary vaginal epithelial cells and vaginal fibroblasts, isolated from the native SVTs on decellularized sheep vaginal matrices at an air-liquid interface. Morphological analyses of the models were conducted by performing hematoxylin and eosin staining and further characterization was done by immunohistofluorescence (IHF) of structural proteins and cytokeratins. Histological analysis of the models revealed a gradual formation of a stratified epithelium on our decellularized matrices and cell metabolic activity remained high for 21 days as measured by the resazurin assay. Our models showed a dose-dependent response to estradiol-17β [E In this study, we have developed an estradiol-responsive TE vaginal model that closely mimics the structural and physiological properties of the native SVT.
Identifiants
pubmed: 35312089
doi: 10.1002/nau.24908
pmc: PMC9313856
doi:
Substances chimiques
Estradiol
4TI98Z838E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
905-917Informations de copyright
© 2022 The Authors. Neurourology and Urodynamics published by Wiley Periodicals LLC.
Références
Mol Cell Endocrinol. 2000 Jun;164(1-2):225-37
pubmed: 11026574
Neurourol Urodyn. 2022 Apr;41(4):905-917
pubmed: 35312089
Expert Opin Biol Ther. 2010 Dec;10(12):1717-28
pubmed: 21058932
Am J Reprod Immunol. 2011 Mar;65(3):268-78
pubmed: 21223429
Nat Rev Urol. 2019 Nov;16(11):675-689
pubmed: 31548731
Cell. 1975 Nov;6(3):331-43
pubmed: 1052771
Expert Rev Obstet Gynecol. 2012 May 1;7(3):249-260
pubmed: 22707980
Methods Mol Biol. 2011;740:27-32
pubmed: 21468965
Histochem J. 1986 Oct;18(10):565-75
pubmed: 2433255
Int J Impot Res. 2013 Sep;25(5):172-7
pubmed: 23552580
Differentiation. 1986;31(2):141-53
pubmed: 2427382
Histochem J. 1979 Jul;11(4):447-55
pubmed: 91593
Endocrinology. 1998 Oct;139(10):4345-52
pubmed: 9751518
Pharmacol Rep. 2017 Oct;69(5):861-870
pubmed: 28623710
Toxicology. 2011 Jan 11;279(1-3):130-8
pubmed: 20937349
Maturitas. 2007 Dec 20;58(4):366-76
pubmed: 17997058
Altern Lab Anim. 2011 Sep;39(4):317-37
pubmed: 21942546
Biomaterials. 2019 Dec;225:119495
pubmed: 31606680
Eur Urol. 2017 Sep;72(3):424-431
pubmed: 28413126
Cancer. 1994 Oct 15;74(8):2314-20
pubmed: 7522949
Transgend Health. 2018 May 01;3(1):74-81
pubmed: 29756046
Reprod Sci. 2021 Jun;28(6):1759-1773
pubmed: 33825165
J Biomed Res. 2017 Jan 19;31(3):240-247
pubmed: 28808216
Biol Reprod. 2011 Jul;85(1):97-104
pubmed: 21471299
Eur J Obstet Gynecol Reprod Biol. 2009 May;144 Suppl 1:S146-58
pubmed: 19285776
J Biomed Mater Res A. 2017 Jul;105(7):1949-1959
pubmed: 28294563
Obstet Gynecol. 2003 Sep;102(3):571-82
pubmed: 12962945
Biotech Histochem. 2012 May;87(4):241-8
pubmed: 21958122
Trends Endocrinol Metab. 2010 Aug;21(8):504-11
pubmed: 20456973
Toxicol In Vitro. 2006 Aug;20(5):689-98
pubmed: 16309879